Effect Modification of the Association Between Race and Stage at Colorectal Cancer Diagnosis by Socioeconomic Status.

J Public Health Manag Pract

Department of Biostatistics and Epidemiology, Hudson College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma (Ms McGrew and Drs Peck, Vesely, Janitz, and Campbell); and Oklahoma Area Tribal Epidemiology Center, Southern Plains Tribal Health Board, Oklahoma City, Oklahoma (Messrs Snider and Dougherty).

Published: September 2020

Objectives: To compare risks of distant-stage colorectal cancer (CRC) diagnosis between whites and American Indian/Alaska Natives (AI/ANs) and to explore effect modification by area-based socioeconomic status (SES).

Design: Retrospective cohort study using data from the Oklahoma Central Cancer Registry.

Setting: Oklahoma.

Participants: White and AI/AN cases of CRC diagnosed in Oklahoma between 2001 and 2008 (N = 8 438). A subanalysis was performed on the cohort of those aged 50 years and older (N = 7 728).

Main Outcome Measure: Risk of distant-stage CRC diagnosis stratified by SES score.

Results: Race and SES were independently associated with distant-stage diagnosis. In SES-stratified analyses, AI/ANs in the 2 lowest SES groups experienced increased risks in the overall cohort and among those aged 50 years and older. In multivariable models, risks remained significant among those aged 50 years and older in the lowest SES groups (Adjusted risk ratio SES score of 2: 1.31, 95% confidence interval: 1.06-1.63 and adjusted risk ratio SES score of 1: 1.21, 95% confidence interval: 1.01-1.44).

Conclusion: Socioeconomic status is an effect modifier in the association between race/ethnicity and stage at CRC diagnosis. Disparities in stage at CRC diagnosis exist between AI/ANs and whites with lower estimated SES. Efforts are needed to increase CRC screening among lower SES AI/ANs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043013PMC
http://dx.doi.org/10.1097/PHH.0000000000000993DOI Listing

Publication Analysis

Top Keywords

crc diagnosis
16
socioeconomic status
12
aged years
12
years older
12
colorectal cancer
8
cohort aged
8
ses
8
lowest ses
8
ses groups
8
adjusted risk
8

Similar Publications

Background: Up to 23% of breast cancer patients recurred within a decade after trastuzumab treatment. Conversely, one trial found that patients with low HER2 expression and metastatic breast cancer had a positive response to trastuzumab-deruxtecan (T-Dxd). This indicates that relying solely on HER2 as a single diagnostic marker to predict the efficacy of anti-HER2 drugs is insufficient.

View Article and Find Full Text PDF

Background: Microsatellite instability-high (MSI-H) metastatic colorectal cancer (CRC) patients are the dominant population in immune checkpoint blockade treatments, while more than half of them could not benefit from single-agent immunotherapy. We tried to identify the biomarker of MSI-H CRC and explore its role and mechanism in anti-PD-1 treatments. Tumor-specific MHC-II was linked to a better response to anti-PD-1 in MSI-H CRC and CD74 promoted assembly and transport of HLA-DR dimers.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a histologically heterogeneous disease with variable clinical outcome. The role the tumour microenvironment (TME) plays in determining tumour progression is complex and not fully understood. To improve our understanding, it is critical that the TME is studied systematically within clinically annotated patient cohorts with long-term follow-up.

View Article and Find Full Text PDF

Objectives: To prevent colorectal cancer (CRC), most patients with familial adenomatous polyposis (FAP) undergo (procto)colectomy with ileorectal anastomosis (IRA) or ileal pouch-anal anastomosis (IPAA). After surgery, these patients remain at risk of developing cancer in the remnant rectum or rectal cuff/pouch. We aimed to compare the long-term risk of cancer following IRA or IPAA in FAP.

View Article and Find Full Text PDF

Background: Brain fluid flow plays a crucial role in maintaining brain health by eliminating potentially harmful waste products like amyloid-beta and tau [1-2]. This process is potentially facilitated by pulsations in the perivascular space, influenced by the neurovascular unit and autonomic nervous system, which may vary in brain diseases such as Alzheimer's disease (AD) [3-4]. Using a 7 Tesla MRI scanner and ultrafast echo-planar imaging (EPI), we developed a non-invasive neuroimaging methodology to characterize the in-vivo frequency and amplitude responses of pulsations of cerebrospinal fluid (CSF) flow.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!